OKYO Pharma Limited Share Price

OKYO Pharma Limited Share Price

NASDAQ: OKYO
$1.45
-$0.04 (-2.68%) Last updated on 31 Oct, 2026 | 01:24 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

OKYO Pharma Limited Stock Performance

Open
$1.47
Prev. Close
$1.49
Circuit Range
N/A
Day Range
$1.45 - $1.48
Year Range
$1.29 - $3.17
Volume
1,101
Average Traded
$1.47

OKYO Pharma Limited Share Price Today

As of 31 October 2026, OKYO Pharma Limited's share price is $1.45. The stock opened at $1.47, compared to its previous close of $1.49. During today's trading session, OKYO Pharma Limited's share price traded between $1.45 and $1.48, with an average price of $1.46. Over the past 52 weeks, the stock has recorded a high of $3.17 and a low of $1.29. In terms of performance, OKYO Pharma Limited's share price has declined by 9.38% over the last six months and is down 46.98% on a year-on-year basis.

OKYO Pharma Limited Share Price Chart

Line chart of the OKYO Pharma Limited price trend over the selected period. The price fell overall, ranging from 1.40 to 1.48, ending at 1.45.
$1.45$1.48
L
Show Current Price
H

OKYO Pharma Limited Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

OKYO Pharma Limited Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.27-$16.83-$4.71-$8.95
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-26.83%72.01%-90.02%

About OKYO Pharma Limited

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.

OKYO Pharma Limited Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.30
$1.47
+8.09%
Sep 2026
$1.51
$1.36
-12.26%
Aug 2026
$1.66
$1.55
-7.74%
Jul 2026
$1.51
$1.68
+12.00%
Jun 2026
$1.75
$1.50
-13.04%
May 2026
$1.72
$1.73
+7.81%
Apr 2026
$1.67
$1.60
-0.31%
Mar 2026
$1.68
$1.60
-5.31%
Feb 2026
$1.98
$1.70
-16.30%
Jan 2026
$2.05
$2.02
+0.80%
Dec 2025
$1.94
$2.01
+2.50%
Nov 2025
$2.70
$1.96
-28.34%

OKYO Share Price FAQs